EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer—A Single Institution Retrospective Study

Mame Daro Faye iD, Mariana Petruccelli Araujo, Michel D Wissing, Khalid Alrabiah, Lucy Gilbert iD, Xing Zeng, Luis Souhami, Joanne Alfieri iD

Current Oncology · 13.05.2023 · 30 (5) · 4966-4978

DOI: 10.3390/curroncol30050375 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 13.05.2023. Verfasst von Mame Daro Faye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Brachytherapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The treatment paradigm for locally advanced cervical cancer (LACC) has shifted from two-dimensional-brachytherapy (2D-BT) to three-dimensional-image-guided adaptive BT (3D-IGABT). In this retrospective study, we report our experience with the change from 2D-BT to 3D-IGABT.

Methods

We reviewed 146 LACC patients (98 3D-IGABT and 48 2D-BT) who received chemoradiation between 2004 and 2019. The multivariable odds ratio (OR) for treatment-related toxicities and hazard ratios (HR) for locoregional control (LRC), distant control (DC), failure-free survival (FFS), cancer-specific survival (CSS) and overall survival (OS) are reported.

Results

The median follow-up was 50.3 months. There was a significant decrease in overall late toxicities in the 3D-IGABT group compared to the 2D-BT group (OR 0.22[0.10–0.52]), late gastrointestinal (OR 0.31[0.10–0.93]), genitourinary (OR 0.31[0.09–1.01]) and vaginal toxicities (0% vs. 29.6%). Grade ≥ 3 toxicity was low in both groups (2D-BT: 8.2% acute, 13.3% late vs. 3D-IGABT: 6.3% acute, 4.4% late, NS). The five-year LRC, DC, FFS, CSS and OS for 3D-IGABT were 92.0%, 63.4%, 61.7%, 75.4% and 73.6%, compared to 87.3%, 71.8%, 63.7%, 76.3% and 70.8% for 2D-BT (NS).

Conclusions

3D-IGABT for the treatment of LACC is associated with a decrease in overall late gastrointestinal, genitourinary and vaginal toxicities. The disease control or survival outcomes were comparable to contemporary 3D-IGABT studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsBrachytherapyFemaleHumansRetrospective StudiesProportional Hazards Models

Stichwörter der Autor:innen

3D-IGABTbrachytherapycervical cancerradiation oncologyradiotherapy

Autor:innen und Institutionen

  • Division of Radiation Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
  • Division of Cancer Epidemiology, Oncology, McGill University, Montreal, QC H4A 3T2, Canada.
  • Department of Gynecology-Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.

ORCID-Profile: Mame Daro Faye, Lucy Gilbert, Joanne Alfieri

Zitieren

APA

Faye, M. D., Petruccelli Araujo, M., Wissing, M. D., Alrabiah, K., Gilbert, L., Zeng, X., Souhami, L., & Alfieri, J. (2023). Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer—A Single Institution Retrospective Study. Current Oncology, 30(5), 4966-4978. https://doi.org/10.3390/curroncol30050375

Vancouver

Faye MD, Petruccelli Araujo M, Wissing MD, Alrabiah K, Gilbert L, Zeng X, et al. Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer—A Single Institution Retrospective Study. Current Oncology. 2023;30(5):4966-4978. doi:10.3390/curroncol30050375

BibTeX
@article{Faye2023,
  author = {Faye, Mame Daro and Petruccelli Araujo, Mariana and Wissing, Michel D and Alrabiah, Khalid and Gilbert, Lucy and Zeng, Xing and Souhami, Luis and Alfieri, Joanne},
  title = {Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer—A Single Institution Retrospective Study},
  journal = {Current Oncology},
  year = {2023},
  volume = {30},
  number = {5},
  pages = {4966--4978},
  doi = {10.3390/curroncol30050375}
}
Kostenlos starten →